Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which spinal anesthetic gets you back on your feet sooner?

NCT ID NCT07777055

Disease control Sponsor: Tribhuvan University, Nepal Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 20, 2026 · Last updated Aug 25, 2026 · Updated 3 times

Summary

This trial compares two common spinal anesthetics, bupivacaine and ropivacaine, to see which one wears off faster, allowing patients to move their legs sooner after lower limb surgery. The study involves adults having elective orthopedic procedures and measures how long each drug blocks movement and sensation. The goal is to find out if ropivacaine truly offers a quicker recovery, as earlier research suggests.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Spinal anesthesia with either 0.5% hyperbaric bupivacaine or 0.75% isobaric ropivacaine
What this could lead to
If one drug proves better, it could lead to faster recovery and earlier mobility after surgery, improving patient comfort and hospital efficiency.
What could go wrong
This is a small, single-center trial, and results may not apply to all patients. Both drugs have known risks like low blood pressure and temporary leg weakness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

64 people

The number who actually took part.

Started

Dec 2018

Finished

Nov 2019

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. AGE: \>18 years\>65years 2. All ASA I and II patients 3. Undergoing elective orthopaedic surgeries 4. No contraindications for spinal anesthesia Exclusion Criteria: 1. pregnancy, 2. obesity, 3. ASA III and IV, 4. emergency surgeries.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Spinal anesthesia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Spinal anesthesia

Contacts and locations

Locations

  • Institute of Medicine

    Kathmandu, Bagmati, Nepal

More trials for these conditions

Other studies related to the condition(s) this trial covers.